Oncternal Therapeutics (NASDAQ:ONCT) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research report sent to investors on Saturday. The firm issued a sell rating on the stock. Oncternal Therapeutics Stock Down 7.2 % Shares of Oncternal Therapeutics stock opened at $0.29 on Friday. The firm has a market cap of $17.37 million, […]

Related Keywords

,Oncternal Therapeutics Inc ,Vanguard Group Inc ,Millennium Management ,Healthcare Of Ontario Pension Plan Trust Fund ,Oncternal Therapeutics Company Profile ,Richmond Brothers Inc ,Renaissance Technologies ,Oncternal Therapeutics ,Free Report ,Therapeutics Stock Down ,Ontario Pension Plan Trust Fund ,Get Free Report ,Orphan Receptor ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Initiated Coverage ,Stocknews Com ,